market valuation

Alphabet poised to become world's most valuable company, driven by Google Cloud's 63% revenue growth and 81% profit surge, with $126.8B cash reserves.

S&P 500 hits fresh records on improved Iran peace sentiment and falling oil prices, with tech stocks leading. However, valuations at historic extremes leave market vulnerable to geopolitical or earnings disappointments.

SpaceX's $1.75 trillion IPO could face steep first-year declines. Historical data shows median 31% drops for mega-IPOs, suggesting patient investors should wait for corrections.

Nvidia's stock has split 480-for-1 since 2000 but requires 100-200% more gains before next split, likely years away.

Corporate buybacks totaling $7 trillion since 2018 have driven Wall Street's bull market, enabled by Trump's 2017 tax cuts. Yet soaring valuations raise sustainability concerns.

$NVDA regains $5 trillion market cap with potential to become world's first $10 trillion company within three years, driven by AI inference dominance.

Nvidia approaches historic $6 trillion valuation milestone with stock trading at reasonable 25x forward earnings, but investors should adopt 3-5 year time horizons due to AI spending cyclicality risks.

SpaceX targets $2T IPO, but history of tech IPO reversals—Palantir, Snowflake, Figma—suggests waiting for cooler valuations.

Amazon ($AMZN) at $2.7T offers growth via cloud and advertising; Costco ($COST) at $449B provides stability through membership model and dividends.

SpaceX and OpenAI IPOs loom in 2026 with record valuations. Historical data shows the 10 largest U.S. IPOs declined 26% median in year one.

New Berkshire CEO Greg Abel shifts strategy away from American equities, investing over $43 billion in Japanese trading houses and insurers citing attractive valuations.

TSMC's strong Q1 growth keeps it pivotal to AI, but Nvidia's faster expansion widens the valuation gap between the $1.9T and $4.9T giants.

Costco and Palantir offer compelling growth but trade at stretched valuations—a 52x P/E and 231x earnings respectively—making them more attractive entry points during market corrections.

Eli Lilly received FDA approval for Foundayo weight-loss pill in April 2026. With 40%+ growth and premium valuation, stock needs only 20% gain to hit $1 trillion market cap.

Wall Street's historic Iran ceasefire rally faces reality as persistent inflation and record valuations limit upside despite falling oil prices.

S&P 500 and Nasdaq hit records amid 3.3% inflation and historically elevated valuations, raising correction concerns.

Tesla and Rivian positioned for $1 trillion combined upside through robotaxi autonomy and mass-market EV scaling, with Uber's $1.25 billion investment supporting Rivian's growth.

SpaceX prepares for potentially largest IPO ever at $1.75T valuation, but historical mega-IPO trends suggest 10% post-launch decline could wipe $175B.

Nvidia ($NVDA), valued at $4.8 trillion, could potentially reach $10 trillion by 2030 with projected annual sales growth of 79-85% and $1 trillion from new Blackwell and Vera Rubin chips.

Eli Lilly reaches $1 trillion valuation while outperforming Novo Nordisk over three years, driven by superior weight-loss drug efficacy and robust pipeline strength.